BridgeBio Pharma Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 16.86 M | $1.29 B | 0.18% | 8.85% |
| BLACKROCK, INC. | 02/12/2026 | 14.55 M | $1.11 B | 0.96% | 7.64% |
| VIKING GLOBAL INVESTORS LP | 02/17/2026 | 14.39 M | $1.10 B | -9.91% | 7.56% |
| KOHLBERG KRAVIS ROBERTS & CO. L.P. | 02/17/2026 | 13.26 M | $1.01 B | 0.00% | 6.96% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 11.00 M | $841.35 M | 25.85% | 5.77% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/17/2026 | 9.00 M | $688.29 M | 9.84% | 4.72% |
| AISLING CAPITAL MANAGEMENT LP | 02/10/2026 | 5.09 M | $389.30 M | -16.42% | 2.67% |
| STATE STREET CORP | 02/13/2026 | 4.96 M | $379.61 M | -11.48% | 2.60% |
| INVESCO LTD. | 02/19/2026 | 4.83 M | $369.55 M | 22.98% | 2.54% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 4.41 M | $344.69 M | 12.85% | 2.32% |
| UBS GROUP AG | 01/29/2026 | 3.86 M | $295.52 M | 0.00% | 2.03% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 3.83 M | $292.86 M | 144.25% | 2.01% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/13/2026 | 3.55 M | $271.20 M | -7.80% | 1.86% |
| JANE STREET GROUP, LLC | 02/12/2026 | 3.42 M | $261.37 M | 2.04% | 1.79% |
| BROOKLANDS FUND MANAGEMENT LTD | 02/17/2026 | 2.75 M | $2.81 M | 100.00% | 1.44% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 2.67 M | $204.25 M | -10.34% | 1.40% |
| FMR LLC | 02/17/2026 | 2.39 M | $182.84 M | 40.55% | 1.25% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 2.35 M | $179.65 M | 130.45% | 1.23% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 2.21 M | $169.35 M | -1.72% | 1.16% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 2.16 M | $165.60 M | 49.92% | 1.14% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 2.05 M | $156.86 M | -11.94% | 1.08% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/13/2026 | 1.98 M | $151.01 M | 3.16% | 1.04% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.96 M | $150.26 M | 2.04% | 1.03% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 1.95 M | $148.93 M | -16.40% | 1.02% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 02/11/2026 | 1.93 M | $147.99 M | 0.08% | 1.02% |
| UBS GROUP AG | 01/29/2026 | 1.88 M | $143.47 M | -27.48% | 0.98% |
| SC US (TTGP), LTD. | 02/13/2026 | 1.86 M | $142.30 M | 0.00% | 0.98% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.78 M | $136.37 M | -19.30% | 0.94% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 1.73 M | $131.97 M | 100.00% | 0.91% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.68 M | $128.58 M | 1.14% | 0.88% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 1.59 M | $121.82 M | 149.14% | 0.84% |
| NORGES BANK | 02/10/2026 | 1.53 M | $116.80 M | 100.00% | 0.80% |
| LAURION CAPITAL MANAGEMENT LP | 02/17/2026 | 1.40 M | $107.25 M | -20.04% | 0.74% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 1.40 M | $107.17 M | -15.74% | 0.74% |
| MORGAN STANLEY | 02/13/2026 | 1.40 M | $107.07 M | 32.70% | 0.73% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.35 M | $103.01 M | -3.97% | 0.71% |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 1.31 M | $100.53 M | 3.70% | 0.69% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 1.30 M | $99.39 M | 32.44% | 0.68% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 1.27 M | $96.96 M | 12.08% | 0.67% |
| ENSIGN PEAK ADVISORS, INC | 02/12/2026 | 1.26 M | $96.64 M | -6.52% | 0.66% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.26 M | $96.01 M | 0.94% | 0.66% |
| CORMORANT ASSET MANAGEMENT, LP | 02/17/2026 | 1.20 M | $91.79 M | -14.29% | 0.63% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 1.11 M | $84.66 M | 2.81% | 0.58% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.08 M | $82.46 M | -21.93% | 0.57% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 01/15/2026 | 994.22 K | $77.78 M | 14,211.50% | 0.52% |
| JPMORGAN CHASE & CO | 02/11/2026 | 858.97 K | $65.70 M | 192.05% | 0.45% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 841.54 K | $64.37 M | 5.10% | 0.44% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 02/17/2026 | 826.13 K | $63.19 M | 25.24% | 0.43% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 02/17/2026 | 813.79 K | $62.25 M | 0.88% | 0.43% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 810.14 K | $61.97 M | -32.49% | 0.43% |
BridgeBio Pharma Inc institutional Ownership - FAQ's
During the previous two years, 576 institutional investors and hedge funds held shares of BridgeBio Pharma Inc. The most heavily invested institutionals were:
Aisling Capital Management LP: 5.09 M
Invesco Ltd.: 4.59 M
UBS Group AG: 2.03 M
JANE STREET GROUP, LLC: 1.76 M
Pictet Asset Management Holding SA: 1.38 M
PRINCIPAL FINANCIAL GROUP INC: 1.33 M
100.29% of BridgeBio Pharma Inc stock is owned by institutional investors.
Institutional investors have bought a total of 216.94 M shares in the last 24 months. This purchase volume represents approximately $14.24 B in transactions.